Anti-EGFL8/ C6orf8/ NG3 functional antibody

Anti-EGFL8/ C6orf8/ NG3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EGFL8/EGFL8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0901-Ab-1/ GM-Tg-hg-SE0901-Ab-2Anti-Human EGFL8 monoclonal antibodyHuman
GM-Tg-rg-SE0901-Ab-1/ GM-Tg-rg-SE0901-Ab-2Anti-Rat EGFL8 monoclonal antibodyRat
GM-Tg-mg-SE0901-Ab-1/ GM-Tg-mg-SE0901-Ab-2Anti-Mouse EGFL8 monoclonal antibodyMouse
GM-Tg-cynog-SE0901-Ab-1/ GM-Tg-cynog-SE0901-Ab-2Anti-Cynomolgus/ Rhesus macaque EGFL8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0901-Ab-1/ GM-Tg-felg-SE0901-Ab-2Anti-Feline EGFL8 monoclonal antibodyFeline
GM-Tg-cang-SE0901-Ab-1/ GM-Tg-cang-SE0901-Ab-2Anti-Canine EGFL8 monoclonal antibodyCanine
GM-Tg-bovg-SE0901-Ab-1/ GM-Tg-bovg-SE0901-Ab-2Anti-Bovine EGFL8 monoclonal antibodyBovine
GM-Tg-equg-SE0901-Ab-1/ GM-Tg-equg-SE0901-Ab-2Anti-Equine EGFL8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0901-Ab-1/ GM-Tg-hg-SE0901-Ab-2; GM-Tg-rg-SE0901-Ab-1/ GM-Tg-rg-SE0901-Ab-2;
GM-Tg-mg-SE0901-Ab-1/ GM-Tg-mg-SE0901-Ab-2; GM-Tg-cynog-SE0901-Ab-1/ GM-Tg-cynog-SE0901-Ab-2;
GM-Tg-felg-SE0901-Ab-1/ GM-Tg-felg-SE0901-Ab-2; GM-Tg-cang-SE0901-Ab-1/ GM-Tg-cang-SE0901-Ab-2;
GM-Tg-bovg-SE0901-Ab-1/ GM-Tg-bovg-SE0901-Ab-2; GM-Tg-equg-SE0901-Ab-1/ GM-Tg-equg-SE0901-Ab-2
Products NameAnti-EGFL8 monoclonal antibody
Formatmab
Target NameEGFL8
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EGFL8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0901-Ag-1Recombinant multi-species EGFL8/ C6orf8/ NG3 protein
    CytokineGM-Tg-g-SE0901-Ag-1EGF-like-domain, multiple 8 (EGFL8) protein
    ORF Viral VectorpGMLP004973human EGFL8 Lentivirus plasmid
    ORF Viral VectorvGMLP004973human EGFL8 Lentivirus particle
    ORF Viral VectorpGMLPm004581mouse Egfl8 Lentivirus plasmid
    ORF Viral VectorvGMLPm004581mouse Egfl8 Lentivirus particle


    Target information

    Target IDGM-SE0901
    Target NameEGFL8
    Gene ID80864,81701,406166,717145,481725,101095824,782820
    Gene Symbol and SynonymsAGPAT1,C6orf8,EGFL8,NG3
    Uniprot AccessionQ99944,Q6MG84
    Uniprot Entry NameEGFL8_HUMAN,EGFL8_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000241404
    Target ClassificationN/A

    The target: EGFL8, gene name: EGFL8, also named as C6orf8, NG3. Predicted to enable signaling receptor binding activity. Predicted to be involved in anatomical structure development. Predicted to act upstream of or within in utero embryonic development. Predicted to be active in cell surface and extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.